BioAtla
BCAB
BCAB
91 hedge funds and large institutions have $279M invested in BioAtla in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% more capital invested
Capital invested by funds: $208M → $279M (+$70.6M)
25% more funds holding
Funds holding: 73 → 91 (+18)
1.1% less ownership
Funds ownership: 74.51% → 73.41% (-1.1%)
Holders
91
Holding in Top 10
2
Calls
$1.22M
Puts
$625K
Top Buyers
| 1 | +$14.4M | |
| 2 | +$12.4M | |
| 3 | +$10.4M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.55M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.28M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$6.62M | |
| 3 | -$6.12M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$4.43M |
| 5 |
ACM
Altium Capital Management
New York
|
-$4.26M |